• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TNFα/TNFR2 信号通路:间充质干细胞免疫调节功能的活跃免疫检查点。

TNFα/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function.

机构信息

INSERM UMR-S-MD 1197, Hôpital Paul Brousse, Villejuif, France.

National Institute of Applied Sciences and Technology (INSAT), Carthage University, LR18ES40, Inflammation, environment and signalization pathologies, Tunis, Tunisia.

出版信息

Stem Cell Res Ther. 2020 Jul 16;11(1):281. doi: 10.1186/s13287-020-01740-5.

DOI:10.1186/s13287-020-01740-5
PMID:32669116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7364521/
Abstract

BACKGROUND

In addition to their multilineage potential, mesenchymal stem cells (MSCs) have a broad range of functions from tissue regeneration to immunomodulation. MSCs have the ability to modulate the immune response and change the progression of different inflammatory and autoimmune disorders. However, there are still many challenges to overcome before their widespread clinical administration including the mechanisms behind their immunoregulatory function. MSCs inhibit effector T cells and other immune cells, while inducing regulatory T cells (T regs), thus, reducing directly and indirectly the production of pro-inflammatory cytokines. TNF/TNFR signaling plays a dual role: while the interaction of TNFα with TNFR1 mediates pro-inflammatory effects and cell death, its interaction with TNFR2 mediates anti-inflammatory effects and cell survival. Many immunosuppressive cells like T regs, regulatory B cells (B regs), endothelial progenitor cells (EPCs), and myeloid-derived suppressor cells (MDSCs) express TNFR2, and this is directly related to their immunosuppression efficiency. In this article, we investigated the role of the TNFα/TNFR2 immune checkpoint signaling pathway in the immunomodulatory capacities of MSCs.

METHODS

Co-cultures of MSCs from wild-type (WT) and TNFR2 knocked-out (TNFR2 KO) mice with T cells (WT and TNFα KO) were performed under various experimental conditions.

RESULTS

We demonstrate that TNFR2 is a key regulatory molecule which is strongly involved in the immunomodulatory properties of MSCs. This includes their ability to suppress T cell proliferation, activation, and pro-inflammatory cytokine production, in addition to their capacity to induce active T regs.

CONCLUSIONS

Our results reveal for the first time the importance of the TNFα/TNFR2 axis as an active immune checkpoint regulating MSC immunological functions.

摘要

背景

除了多能性,间充质干细胞(MSCs)具有广泛的功能,从组织再生到免疫调节。MSCs 能够调节免疫反应,改变不同炎症和自身免疫性疾病的进展。然而,在广泛的临床应用之前,仍然有许多挑战需要克服,包括其免疫调节功能背后的机制。MSCs 抑制效应 T 细胞和其他免疫细胞,同时诱导调节性 T 细胞(Tregs),从而减少促炎细胞因子的直接和间接产生。TNF/TNFR 信号传导发挥双重作用:TNFα 与 TNFR1 的相互作用介导促炎作用和细胞死亡,而与 TNFR2 的相互作用介导抗炎作用和细胞存活。许多免疫抑制细胞,如 Tregs、调节性 B 细胞(Bregs)、内皮祖细胞(EPCs)和髓系来源的抑制细胞(MDSCs),表达 TNFR2,这与其免疫抑制效率直接相关。在本文中,我们研究了 TNFα/TNFR2 免疫检查点信号通路在 MSCs 免疫调节能力中的作用。

方法

在各种实验条件下,将野生型(WT)和 TNFR2 敲除(TNFR2 KO)小鼠的 MSCs 与 T 细胞(WT 和 TNFα KO)共培养。

结果

我们证明 TNFR2 是一个关键的调节分子,它强烈参与 MSCs 的免疫调节特性。这包括它们抑制 T 细胞增殖、活化和促炎细胞因子产生的能力,以及它们诱导活性 Tregs 的能力。

结论

我们的结果首次揭示了 TNFα/TNFR2 轴作为调节 MSC 免疫功能的主动免疫检查点的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/d6e5b26adbb8/13287_2020_1740_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/0c30bb2529ca/13287_2020_1740_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/be89a0ed4c0a/13287_2020_1740_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/e67c127ad3ed/13287_2020_1740_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/eaef7ac183d4/13287_2020_1740_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/e0756bdb9fc2/13287_2020_1740_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/93ddc66b5ccf/13287_2020_1740_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/d6e5b26adbb8/13287_2020_1740_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/0c30bb2529ca/13287_2020_1740_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/be89a0ed4c0a/13287_2020_1740_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/e67c127ad3ed/13287_2020_1740_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/eaef7ac183d4/13287_2020_1740_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/e0756bdb9fc2/13287_2020_1740_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/93ddc66b5ccf/13287_2020_1740_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cfe/7364521/d6e5b26adbb8/13287_2020_1740_Fig7_HTML.jpg

相似文献

1
TNFα/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function.TNFα/TNFR2 信号通路:间充质干细胞免疫调节功能的活跃免疫检查点。
Stem Cell Res Ther. 2020 Jul 16;11(1):281. doi: 10.1186/s13287-020-01740-5.
2
TNFα-TNFR2 signaling pathway in control of the neural stem/progenitor cell immunosuppressive effect: Different experimental approaches to assess this hypothetical mechanism behind their immunological function.TNFα-TNFR2 信号通路在控制神经干细胞/祖细胞免疫抑制作用中的作用:评估其免疫功能背后这一假设机制的不同实验方法。
Stem Cell Res Ther. 2020 Jul 22;11(1):307. doi: 10.1186/s13287-020-01816-2.
3
The TNF/TNFR2 signaling pathway is a key regulatory factor in endothelial progenitor cell immunosuppressive effect.TNF/TNFR2 信号通路是内皮祖细胞免疫抑制作用的关键调节因子。
Cell Commun Signal. 2020 Jun 16;18(1):94. doi: 10.1186/s12964-020-00564-3.
4
TNFα priming through its interaction with TNFR2 enhances endothelial progenitor cell immunosuppressive effect: new hope for their widespread clinical application.TNFα 通过与其受体 TNFR2 的相互作用进行激活预处理,增强了内皮祖细胞的免疫抑制作用:为其广泛的临床应用带来了新的希望。
Cell Commun Signal. 2021 Jan 4;19(1):1. doi: 10.1186/s12964-020-00683-x.
5
Regulatory T cell induction by mesenchymal stem cells depends on the expression of TNFR2 by T cells.间充质干细胞诱导调节性 T 细胞依赖于 T 细胞 TNFR2 的表达。
Stem Cell Res Ther. 2020 Dec 10;11(1):534. doi: 10.1186/s13287-020-02057-z.
6
TNFR2 Is a Crucial Hub Controlling Mesenchymal Stem Cell Biological and Functional Properties.肿瘤坏死因子受体2(TNFR2)是控制间充质干细胞生物学和功能特性的关键枢纽。
Front Cell Dev Biol. 2020 Dec 4;8:596831. doi: 10.3389/fcell.2020.596831. eCollection 2020.
7
Differential roles of TNFα-TNFR1 and TNFα-TNFR2 in the differentiation and function of CD4Foxp3 induced Treg cells in vitro and in vivo periphery in autoimmune diseases.在自身免疫性疾病中,TNFα-TNFR1 和 TNFα-TNFR2 在体外和体内外周 CD4Foxp3 诱导的 Treg 细胞的分化和功能中发挥不同的作用。
Cell Death Dis. 2019 Jan 10;10(1):27. doi: 10.1038/s41419-018-1266-6.
8
TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways.与女性干细胞细胞因子产生相关的TNFR1信号抗性独立于TNFR2介导的途径。
Am J Physiol Regul Integr Comp Physiol. 2008 Oct;295(4):R1124-30. doi: 10.1152/ajpregu.90508.2008. Epub 2008 Aug 6.
9
Human fetal liver MSCs are more effective than adult bone marrow MSCs for their immunosuppressive, immunomodulatory, and Foxp3 T reg induction capacity.人胎肝间充质干细胞比成人骨髓间充质干细胞在免疫抑制、免疫调节和 Foxp3 T 调节诱导能力方面更有效。
Stem Cell Res Ther. 2021 Feb 17;12(1):138. doi: 10.1186/s13287-021-02176-1.
10
MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells.丝裂原活化蛋白激酶(MEK)介导肿瘤坏死因子受体2(TNFR2)与转化生长因子-表皮生长因子受体(TGF-EGFR)之间新的相互作用,以增强人间充质干细胞分泌血管内皮生长因子(VEGF)。
Surgery. 2009 Aug;146(2):198-205. doi: 10.1016/j.surg.2009.04.013. Epub 2009 Jun 25.

引用本文的文献

1
Upfront whole blood transcriptional patterns in patients receiving immune checkpoint inhibitors associate with clinical outcome.接受免疫检查点抑制剂治疗的患者的前期全血转录模式与临床结果相关。
Cancer Immunol Immunother. 2025 Sep 11;74(10):301. doi: 10.1007/s00262-025-04155-4.
2
Mesenchymal stromal cells conditioned by peripheral blood mononuclear cells exert enhanced immunomodulation capacities and alleviate a model of Myasthenia Gravis.经外周血单个核细胞处理的间充质基质细胞具有增强的免疫调节能力,并可缓解重症肌无力模型。
Stem Cell Res Ther. 2025 Aug 8;16(1):437. doi: 10.1186/s13287-025-04534-9.
3
The Role of TNF-α in Neuropathic Pain: An Immunotherapeutic Perspective.

本文引用的文献

1
The TNF/TNFR2 signaling pathway is a key regulatory factor in endothelial progenitor cell immunosuppressive effect.TNF/TNFR2 信号通路是内皮祖细胞免疫抑制作用的关键调节因子。
Cell Commun Signal. 2020 Jun 16;18(1):94. doi: 10.1186/s12964-020-00564-3.
2
Different approaches for transformation of mesenchymal stem cells into hepatocyte-like cells.不同方法将间充质干细胞转化为肝细胞样细胞。
Stem Cell Res Ther. 2020 Feb 7;11(1):54. doi: 10.1186/s13287-020-1555-8.
3
Tumor necrosis factor receptor family costimulation increases regulatory T-cell activation and function via NF-κB.
肿瘤坏死因子-α在神经性疼痛中的作用:免疫治疗视角
Life (Basel). 2025 May 14;15(5):785. doi: 10.3390/life15050785.
4
Role of Tumor Necrosis Factor in Tuberculosis.肿瘤坏死因子在结核病中的作用。
Biomolecules. 2025 May 12;15(5):709. doi: 10.3390/biom15050709.
5
CD163, a novel receptor for TNF, was revealed by proximity ligation assay.通过邻近连接分析揭示了CD163,一种肿瘤坏死因子的新型受体。
Heliyon. 2025 Feb 1;11(3):e42194. doi: 10.1016/j.heliyon.2025.e42194. eCollection 2025 Feb 15.
6
The effects of prenatal administration of tumor necrosis factor-α on osteocalcin and RANK expression in newborn mice.产前给予肿瘤坏死因子-α对新生小鼠骨钙素和RANK表达的影响。
J Mol Histol. 2025 Jan 29;56(2):76. doi: 10.1007/s10735-025-10354-1.
7
Tumor Necrosis Factor Receptor 1 Is Required for Human Umbilical Cord-Derived Mesenchymal Stem Cell-Mediated Rheumatoid Arthritis Therapy.肿瘤坏死因子受体1是人类脐带间充质干细胞介导的类风湿性关节炎治疗所必需的。
Cell Transplant. 2025 Jan-Dec;34:9636897241301703. doi: 10.1177/09636897241301703.
8
In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors.通过溶瘤腺病毒对肿瘤坏死因子-肿瘤坏死因子受体2轴进行原位阻断可提高实体瘤的抗肿瘤疗效。
Mol Ther. 2025 Feb 5;33(2):670-687. doi: 10.1016/j.ymthe.2024.12.011. Epub 2024 Dec 16.
9
Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer.了解 TNFR2 信号在乳腺癌肿瘤微环境中的作用。
J Exp Clin Cancer Res. 2024 Nov 28;43(1):312. doi: 10.1186/s13046-024-03218-1.
10
Engineering mesenchymal stem cells for premature ovarian failure: overcoming challenges and innovating therapeutic strategies.工程间充质干细胞治疗卵巢早衰:克服挑战和创新治疗策略。
Theranostics. 2024 Oct 7;14(17):6487-6515. doi: 10.7150/thno.102641. eCollection 2024.
肿瘤坏死因子受体家族共刺激通过 NF-κB 增加调节性 T 细胞的激活和功能。
Eur J Immunol. 2020 Jul;50(7):972-985. doi: 10.1002/eji.201948393. Epub 2020 Feb 19.
4
The NF-κB RelA Transcription Factor Is Critical for Regulatory T Cell Activation and Stability.NF-κB RelA 转录因子对于调节性 T 细胞的激活和稳定性至关重要。
Front Immunol. 2019 Oct 30;10:2487. doi: 10.3389/fimmu.2019.02487. eCollection 2019.
5
Canine adipose tissue-derived mesenchymal stem cells pre-treated with TNF-alpha enhance immunomodulatory effects in inflammatory bowel disease in mice.经 TNF-α预处理的犬脂肪组织来源间充质干细胞增强了对小鼠炎症性肠病的免疫调节作用。
Res Vet Sci. 2019 Aug;125:176-184. doi: 10.1016/j.rvsc.2019.06.012. Epub 2019 Jun 20.
6
Challenges and Controversies in Human Mesenchymal Stem Cell Therapy.人间充质干细胞治疗中的挑战与争议
Stem Cells Int. 2019 Apr 9;2019:9628536. doi: 10.1155/2019/9628536. eCollection 2019.
7
The Role of TNF-α induced MSCs on Suppressive Inflammation by Increasing TGF-β and IL-10.肿瘤坏死因子-α诱导的间充质干细胞通过增加转化生长因子-β和白细胞介素-10在抑制炎症中的作用。
Open Access Maced J Med Sci. 2018 Oct 4;6(10):1779-1783. doi: 10.3889/oamjms.2018.404. eCollection 2018 Oct 25.
8
Induction of CD4CD25FOXP3 regulatory T cells by mesenchymal stem cells is associated with modulation of ubiquitination factors and TSDR demethylation.间充质干细胞诱导 CD4CD25FOXP3 调节性 T 细胞与泛素化因子的调节和 TSDR 去甲基化有关。
Stem Cell Res Ther. 2018 Oct 25;9(1):273. doi: 10.1186/s13287-018-0991-1.
9
Targeted killing of TNFR2-expressing tumor cells and T by TNFR2 antagonistic antibodies in advanced Sézary syndrome.TNFR2 拮抗抗体靶向杀伤晚期蕈样肉芽肿中表达 TNFR2 的肿瘤细胞和 T 细胞。
Leukemia. 2019 May;33(5):1206-1218. doi: 10.1038/s41375-018-0292-9. Epub 2018 Oct 24.
10
Critical Role of Tumor Necrosis Factor Signaling in Mesenchymal Stem Cell-Based Therapy for Autoimmune and Inflammatory Diseases.肿瘤坏死因子信号通路在基于间充质干细胞的自身免疫性和炎性疾病治疗中的关键作用
Front Immunol. 2018 Jul 20;9:1658. doi: 10.3389/fimmu.2018.01658. eCollection 2018.